|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.080 USD | +0.48% |
|
+2.97% | -61.27% |
| 01:21am | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 09:27pm | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
Company Valuation: Compass Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 309 | 633.5 | 198.8 | 199.5 | 955.1 | 374.6 | - | - |
| Change | - | 105.02% | -68.61% | 0.34% | 378.75% | -60.78% | - | - |
| Enterprise Value (EV) 1 | 309 | 633.5 | 198.8 | 72.78 | 955.1 | 224.6 | 242.6 | 296.6 |
| Change | - | 105.02% | -68.61% | -63.39% | 1,212.3% | -76.49% | 8.01% | 22.26% |
| P/E | -2.42x | -13.6x | -4.73x | -4.03x | -12.8x | -4.75x | -4.47x | -14.5x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | 0.4x | -0.44x | -0.8x | -1.12x | -0.72x | 0.2x |
| Capitalization / Revenue | - | - | - | 235x | - | -169x | 14.6x | 2.95x |
| EV / Revenue | - | - | - | 85.6x | - | -101x | 9.45x | 2.34x |
| EV / EBITDA | -3.8x | -15.5x | -4x | -1.3x | -13.2x | -2.56x | -2.56x | -3.28x |
| EV / EBIT | -3.77x | -15.2x | -3.95x | -1.29x | -13.1x | -2.59x | -2.62x | -9.52x |
| EV / FCF | -14.3x | - | - | -1.62x | -19.4x | -2.86x | -3.21x | 22.8x |
| FCF Yield | -6.98% | - | - | -61.7% | -5.15% | -35% | -31.1% | 4.38% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -0.37 | -0.33 | -0.36 | -0.42 | -0.4379 | -0.465 | -0.1433 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | 0.85 | - | -2.215 | 25.67 | 126.9 |
| EBITDA 1 | -81.32 | -40.87 | -49.66 | -56.04 | -72.56 | -87.6 | -94.75 | -90.29 |
| EBIT 1 | -81.88 | -41.66 | -50.36 | -56.62 | -72.84 | -86.55 | -92.75 | -31.14 |
| Net income 1 | -82.18 | -39.22 | -42.49 | -49.38 | -66.49 | -82.94 | -89.85 | -28 |
| Net Debt 1 | - | - | - | -126.7 | - | -150 | -132 | -78 |
| Reference price 2 | 3.170 | 5.030 | 1.560 | 1.450 | 5.370 | 2.080 | 2.080 | 2.080 |
| Nbr of stocks (in thousands) | 97,472 | 125,938 | 127,455 | 137,589 | 177,862 | 180,088 | - | - |
| Announcement Date | 3/18/22 | 3/15/23 | 3/21/24 | 2/27/25 | 3/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.75x | -101.37x | -2.56x | - | 375M | |
| 34.2x | 8.53x | 26.72x | 0.05% | 55.63B | |
| 19.78x | 6x | 13.04x | 1.52% | 52.25B | |
| -18.16x | 4.33x | -7.56x | -.--% | 23.07B | |
| -39.15x | 12.94x | -37.74x | -.--% | 22.41B | |
| 21.62x | 4.23x | 10.97x | -.--% | 17.32B | |
| 22.36x | 4.48x | 14.84x | -.--% | 15.94B | |
| 17.25x | 5x | 11.74x | -.--% | 13.77B | |
| 44.46x | 16.86x | 51x | -.--% | 13.47B | |
| -436.4x | 29.85x | -3327.81x | -.--% | 12.43B | |
| Average | -33.88x | -0.92x | -324.74x | 0.18% | 22.67B | |
| Weighted average by Cap. | -9.79x | 8.61x | -171.80x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMPX Stock
- Valuation Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
